Chronic Fatigue Syndrome Trial, Recruiting NCT06082518 Sponsor: Sunnybrook Health Sciences Centre Condition: Chronic Fatigue Syndrome
Back to Chronic Fatigue Syndrome

Chronic Fatigue Syndrome Trial, Recruiting

NCT06082518
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You are 18 years old or older
  • A doctor or healthcare professional has officially diagnosed you with Post COVID-19 condition (also known as Long COVID)
  • It has been at least 3 months since you had a COVID-19 infection
  • You have been experiencing ongoing fatigue for more than 12 weeks, plus at least one of the following: difficulty thinking clearly or solving problems (sometimes called "brain fog"), or feelings of stress or anxiety

Who may not be able to join:

  • You have a medical condition or health reason that makes it unsafe for you to receive hyperbaric oxygen therapy (a treatment involving pressurised oxygen chambers) — for example, a collapsed lung, unstable heart disease, or needing certain medical infusions to keep your blood pressure stable (confirm with trial site)
  • You had difficulties with thinking, memory, or learning before your COVID-19 infection
  • You have a history of a traumatic brain injury
  • You are unlikely to be able to attend follow-up appointments — for example, if you do not have a fixed home address or are planning to move away from the area
  • You are currently pregnant or planning to become pregnant (if you are someone of childbearing age)

⚠️ Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 28 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Fahad Alam, MD, Sunnybrook Health Sciences Centre

Phone: 416-480-4864

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
2 January 2024
Est. completion
1 May 2027

Where this trial is recruiting

🇨🇦 Canada

Primary endpoints

Recruitment rate - referral; Recruitment rate - inclusion; Recruitment rate - consent; Adherence to HBOT protocol; Adherence to HBOT protocol - satisfaction; Feasibility of Clinical Outcome Measures

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov